MedGizmo - MedGizmo: Diabetes Update, April 2016
24.04.2016, 19:50   MedGizmo

MedGizmo: Diabetes Update, April 2016

Diabetes is one of the biggest healthcare problems. WHO Global report on diabetes notes:  diabetes rates nearly doubled in the past three decades, largely due to increases in obesity and sugary diets. The percentage of adults living with diabetes worldwide grew from 4.7% in 1980 to 8.5% in 2014. About 422 million adults were living with diabetes in 2014, up from 108 million in 1980.
 
Source: World Health Organization (WHO), 2016.

In 2014 $1 out of every $5 of health-care spending in the United States was used to treat diabetes, which is the seventh-leading cause of death and affects 29 million people in the U.S., according to the American Diabetes Association. It is estimated in 2012 $245B were spent in associated diabetes costs. Stakeholders throughout the healthcare industry are seeking any way to reduce diabetes incidence, driving focus to pre-diabetes, a state of slightly elevated blood sugar levels that has been estimated to impact 86M Americans.
This week the statistics from European E-patient Report 2015 was released – it shows the fact that most of diabetic patients in their online conversations discuss medication and diet (34%), and only 4.8% exercise. This is contrary to all propaganda – that exercise is one of the prime factor for diabetes management.
That is why the issue of diabetes care is surfacing as one of the most acute ones. MedGizmo started following diabetes wearables and applications with its three posts: the first described in general the issue of wearables and diabetes and provided some reference information on non-invasive blood sugar testing developments. The second – Diabetes Applications; that third - platforms that help people to manage the diabetes data, as well as some specific wearables.
In this post we provide selected updates on developments in diabetes management that were published in the past couple of months.

The UK's National Health Service is getting ready to make its wearable tech and health management plans a reality. The Diabetes Digital Coach project, which involves giving wearable sensors to patients to use at home is going to start soon. Read about it in the WAREABLE post.


Nightscout Diabetes Care Project
 
Nightscout (CGM in the Cloud) is an open source, DIY project that allows real time access to a CGM data via personal website, smartwatch viewers, or apps and widgets available for smartphones.
Nightscout was developed by parents of children with Type 1 Diabetes and has continued to be developed, maintained, and supported by volunteers. When first implemented, Nightscout was a solution specifically for remote monitoring of Dexcom G4 CGM data. Today, there are Nightscout solutions available for Dexcom G4, Dexcom Share with Android, Dexcom Share with iOS, and Medtronic. The goal of the project is to allow remote monitoring of a T1D’s glucose level using existing monitoring devices.

Watch Doctors’ Channel Video: Artificial Pancreas Arriving as Soon as Next Year
 
Developing a self-regulated system that can accurately measure a patient’s blood-glucose levels, determine the perfect insulin dose for that particular patient at that exact time, and then deliver the insulin through a connected, wearable insulin-pump has been a goal for type-1 diabetes researchers for some time. According to NBC News, this trio of devices (blood-glucose meter, computation device, and insulin pump), also known as the “artificial pancreas,” could be available for patients as soon as next year. Medtronic is expected to release their technology in 2017.

PAQ - wearable insulin delivery device
 
Delivers up to 3 days of continuous pre-set basal insulin plus on- demand mealtime bolus in 2 unit increments.
Patient wears the device on the belly, and a sub-cutaneous (below the skin) canula delivers a continuous basal dose of insulin automatically. There is no need for separate injections. If an extra bolus dose is required at mealtime, the patient presses a button on the side of the PAQ to deliver additional insulin.


 
Suggestic personalized lifestyle programs to revert Type 2 Diabetes
Suggestic tackles type 2 diabetes using machine learning to create personalized interventions and guide users through them towards disease reversal.
Our Lifestyle GPS app works as a personal assistant to help people with diabetes navigate towards a healthier lifestyle. Whether the user needs suggestions on where and what to eat, snack or cook, or have questions about physical activity, Suggestic is always present to answer those questions and guide the person to make small habit changing choices, one decision at a time.
Based on principles of precision medicine, we have developed a multi-layer personalization system that we apply on top of existing evidence-based lifestyle interventions. Following this system allows for different levels of customization according to different levels of data availability.


ZME Science reported: Scientists create graphene patch to help manage diabetes
Dae-Hyeong Kim from the Seoul National University in South Korea created integrated glucose monitoring and diabetes therapy system. As sweat accumulates in the patch, the glucose it contains is monitored electrochemically on a graphene hybrid platform that also supports an array of other sensors (pH, humidity, mechanical strain).
 

BlueStar mobile prescription therapy for 2 diabetes

Mobile Prescription Therapy is a tool that is an important diabetes management. BlueStar helps adults living with type 2 diabetes and their doctors to improve self-management and help decrease A1C
 

Al Jazeera reported:  Skype and diabetes: Doctors embrace tele-health hubs
Some of the facts:

  • National Health Service (NHS) of England to updated advice to local healthcare commissioners encouraging the use of Skype and other social media to help keep young people engaged in their diabetes treatments as they transition from child to adult services. As a result, hospitals in Derby and Southampton are already in the process of setting up remote Skype consultations.
  • Kaiser Permanente, a United States-based healthcare provider, introduced video appointments to help overcome the geographical vastness of the US, which often sees patients driving long distances to see specialists for particular ailments.
  • The demographic of Skype users may suggest that telemedicine may become a permanent part of the NHS landscape. Psychology Online typically has a self-referring demographic of 24 to 45-year-olds. This chimes with the Newham diabetes clinic, which saw 82 percent of its under-50 patients engage in Skype sessions
Sweetch diabetes prediction technology

Sweetch was developed as a platform for any large-scale clinical outcome prediction, and personalized, data-driven, wellness prevention intervention in the most cost-effective patients. Diabetes is our first use case. The system is a “behavioral analytics engine” that takes user habits and spits back a list of personal recommendations to maintain health.


Sugar Streak Apps

Gain Control With Sugar Streak - glucose logbook app for diabetes
Users are rewarded by sticking to their pledge of how many times per day they will record their sugar levels. This helps them build a “streak” that they won’t want to break. Users can earn “glucoins” as their streaks grow, which can then be used to redeem special offers in the Glucoin Market. Physicians can make much better treatment recommendations when their patients supply accurate and robust glucose tracking data.
 
Eversense CGM system: implantable sensor used for 90 days

A new way to continuously monitor glucose levels around-the-clock, without the need for weekly sensor insertions or having to carry another receiving device
The sensor wirelessly sends glucose data to the smart transmitter worn on the upper arm above where the sensor is implanted. In turn, the smart transmitter calculates the current glucose value along with the direction it’s headed, how fast, and whether glucose values are expected to exceed pre-set low and high targets. Data and alerts are simultaneously sent to the smartphone app that provides real-time tracking, intuitive displays to help identify patterns, and information to help stay in control.


And finally, listen to the audio on SoundCloud

Tom Higham, Executive Director of FutureEverything, talks to Natalie Kane about the issues, concerns and aspirations of technology that aims to make life for those with Type 1 diabetes easier. Talking about behaviours, devices, closed loop systems and how to help the parents of Type 1 diabetics, Tom and Natalie look into the future of wearables and medical technology.
 

This concludes our update. Please, comment to vlad@healthapps.website


 
24.04.2016, 19:50   MedGizmo
Image by MedGizmo
Views: 1305

Disclaimer

When we provide links to other Web resources, the Company is not responsible for the accuracy, usefulness, safety, or intellectual property rights of or relating to such content.

Overview and Analysis

of information from Internet resources. Follow our Instagram Daily Feed @MedGizmo, Twitter Daily Feed @MedGizmo.
© 2016 MedGizmo